BMP10 propeptides and related methods

Details BMP10 propeptides and related methods BMP10 propeptides and related methods

2005-05-12

2010-06-22

Nickol, Gary B (Department: 1646)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

C514S002600, C424S198100, C530S350000, C435S069100, C435S069700

Reexamination Certificate

active

07741284

ABSTRACT:
In certain aspects, the present invention provides BMP10 propeptides for use in treating a variety of disorders including heart disorders and other disorders associated with unwanted activity of the mature BMP10 polypeptide. The present invention also provides methods of screening compounds that modulate activity of BMP10.

REFERENCES:
patent: 5637480 (1997-06-01), Celeste et al.
patent: 5808007 (1998-09-01), Lee et al.
patent: 5834179 (1998-11-01), Jones et al.
patent: 6004780 (1999-12-01), Soppet et al.
patent: 6071708 (2000-06-01), Jones et al.
patent: 6656708 (2003-12-01), Yu et al.
patent: 2003/0082233 (2003-05-01), Lyons et al.
patent: 2003/0144176 (2003-07-01), Olson et al.
patent: 2003/0224501 (2003-12-01), Young et al.
patent: 2005/0244867 (2005-11-01), Soppet et al.
patent: WO 94/03600 (1994-02-01), None
patent: WO-94/15965 (1994-07-01), None
patent: WO-94/26893 (1994-11-01), None
patent: WO 95/24474 (1995-09-01), None
patent: WO 96/39431 (1996-12-01), None
patent: WO 99/37320 (1999-07-01), None
patent: WO 00/43781 (2000-07-01), None
patent: WO-01/92298 (2001-12-01), None
patent: WO02/43759 (2002-06-01), None
Kirsch et al., EMBO J., 2000, 19(13):3314-3324.
Pashmforoush et al., Cell, Apr. 2004, 117:373-386.
Srivastava, Nature, Jun. 2004, 429:819-822.
Chen, H., et al., “BMP10 is essential for maintaining cardiac growth during murine cardiogenesis,” Development, 131(9):2219-2231 (Abstract)(2004).
Neuhaus, H., et al., “Heart specific expression of mouseBMP-10a novel member of the TGF-β superfamily,” Mechanisms of Development, 80:181-184 (1999).
Pashmforoush, M., et al., “Nkx2-5 Pathways and Congenital Heart Disease: Loss of Ventricular Myocyte Lineage Specification Leads to Progressive Cardiomyopathy and Complete Heart Block,” Cell, 117:373-386 (2004).
Teichmann, U., and Kessel, M., “Highly restricted BMP10 expression in the trabeculating myocardium of the chick embryo,” Dev Genes Evol., 214:96-98 (2004).
Caricasole et al., “Human growth-differentiation factor 3 (hGDF3): developmental regulation in human teratocarcinoma cell lines and expression in primary testicular germ cell tumours,”Oncogene, 16: 95-103 (1998).
Clark et al., “Human Stellar, Nanog, and GDF3 Genes are Expressed in Pluripotent Cells and Map to Chromosome 12p13, a Hotspot for Teratocarcinoma,”Stem Cells, 22: 169-179 (2004).
Constam et al., “Regulation of Bone Morphogenetic Protein Activity by Pro Domains and Proprotein Convertases”, The Journal of Cell Biology, 144(1):139-149(1999).
Daluiski et al., “Bone Morphogenetic Protein-3 is a Negative Regulatory of Bone Density”, Nature Genetics, 27(1):84-88(2001).
Faucheux et al., “Opposing Actions of BMP3 and TGFbetal in Human Bone Marrow Stromal Cell Growth and Differentiation”, Biochemical and Biophysical Research Communications, 241(3):787-793(1997).
Hino et al., “Bone Morphogenetic Protein-3B (BMP-3B) Gene Expression is Correlated with Differentiation in Rat Calvarial Osteoblasts”, Biochemical and Biophysical Research Communications, 256(2):419-424(1999).
Hino et al. “Bone Morphogenetic Protein-3 Family Members and Their Biological Functions,” Frontiers in Bioscience, 9:1520-1529(2004).
Hino at al., “Coordination of BMP-3b and cerebus is required for head formation of Xenopus embryos”, Developmental Biology, 260(1):138-157(2003).
McPherron et al., “GDF-3 and GDF-9: two new members of the transforming growth factor-beta superfamily containing a novel pattern of cystelnes,”Journal of Biological Chemistry, 268 (5): 3444-9 (1993).
Nagaso et al., “Dual Specificity of Activin Type II Receptor ActRllb in Dorso-Ventral Patterning During Zebrafish Embryogenesis”, Development Growth and Differentiation, 41(2)119-133(1999).
Takao et al., “Identification of Rat Bone Morphogenetic Protein-3b (BMP-3b), a New Member of BMP-3”, Biochemical and Biophysical Research Communications, 219(2)656-662(1996).
Witthuhn et al., “Upregulation of Bone Morphogenetic Protein GDF-3/Vgr-2 Expression in Adipose Tissue of FABP4/aP2 Null Mice,”Cytokine, 14: 129-135 (2001).
Wang et al., “GDF-3 is an adipogenic cytokine under high fat dietary condition,”Biochemical and Biophysical Research Communications, 321: 1024-1031 (2004).
Bork, 2000, Powers and pitfalls in sequence analysis: the 70% hurdle, Genome Res. 10:398-400.
Brenner, 1999, Errors in genome annotation, Trends in Genetics, 15(4):132-133.
Doerks et al., 1998, Protein annotation: detective work for function prediction, Trends in Genetics, 14(6):248-250.
Graddis et al., 2002, Designing proteins that work using recombinant technologies, Curr. Pharm. Biotechnol. 3:285.
Ngo et al., 1994, Computational complexity, protein structure prediction, and the Levinthal paradox. The Protein Folding Problem and Tertiary Structure Prediction, pp. 492-495.
Skolnick et al., 2000, From genes to protein structure and function: novel applications of computational approaches in the genomic era, Trends in Biotech. 18(1):34-39.
Smith et al., 1997, The challenges of genome sequence annotation or “the devil is in the details,” Nature Biotech. 15:1222-1223.
Wells. 1990, Additivity of mutational effects in proteins, Biochemistry 29(37):8509-8517.

Affiliated with

Also associated with

Rating

BMP10 propeptides and related methods does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with BMP10 propeptides and related methods, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and BMP10 propeptides and related methods will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4227093